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Low Ankle-Brachial Index Predicts Cardiovascular Risk
After Acute Ischemic Stroke or Transient Ischemic Attack
Markus A. Busch, MD, MPH; Katrin Lutz; Jens-Eric Röhl, MD;
Bruno Neuner, MD, MSE; Florian Masuhr, MD
Background and Purpose—A low ankle-brachial blood pressure index (ABI) is an established risk marker for
cardiovascular disease and mortality in the general population, but little is known about its prognostic value in
individuals with acute ischemic stroke or transient ischemic attack (TIA).
Methods—An inception cohort of 204 patients with acute ischemic stroke or TIA was followed up for a mean of 2.3 years.
At baseline, patients underwent ABI measurement and were assessed for risk factors, cardiovascular comorbidities, and
cervical or intracranial artery stenosis. The association between low ABI (0.9) and the risk of the composite outcome
of stroke, myocardial infarction, or death was examined by Kaplan–Meier and Cox regression analyses.
Results—A low ABI was found in 63 patients (31%) and was associated with older age, current smoking, hypertension,
peripheral arterial disease, and cervical or intracranial stenosis. During a total of 453.0 person-years of follow-up, 37
patients experienced outcome events (8.2% per person-year), with a higher outcome rate per person-year in patients with
low ABI (12.8% vs 6.3%, P0.03). In survival analysis adjusted for age and stroke etiology, patients with a low ABI
had a 2 times higher risk of stroke, myocardial infarction, or death than those with a normal ABI (hazard ratio2.2; 95%
CI, 1.1 to 4.5). Additional adjustment for risk factors and cardiovascular comorbidities did not attenuate the association.
Conclusions—A low ABI independently predicted subsequent cardiovascular risk and mortality in patients with acute
stroke or TIA. ABI measurement may help to identify high-risk patients for targeted secondary stroke prevention. (Stroke.
2009;40:3700-3705.)
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The ankle-brachial blood pressure index (ABI) is anestablished clinical test for the assessment of peripheral
arterial disease (PAD) and an indicator of generalized ath-
erosclerosis.1–3 A low ABI is associated with increased
mortality and risk of myocardial infarction (MI) and stroke in
the general population, independent of conventional vascular
risk factors and prevalent cardiovascular disease.1,3,4 Recent
evidence suggests that measurement of the ABI may improve
the accuracy of cardiovascular risk prediction beyond tradi-
tional risk factors in the general population.1
In patients with ischemic stroke or transient ischemic
attack (TIA), coexisting symptomatic PAD is a powerful
predictor of long-term cardiovascular risk and mortality.5,6
Yet the prognostic value of a low ABI, which is also a highly
specific and sensitive test for asymptomatic PAD, has not
been established in this population. Two studies recently
reported high prevalences of low ABI among patients with
acute ischemic stroke or TIA, ranging from 34%7 to 51%,8
but information regarding the role of the ABI in predicting
subsequent cardiovascular risk was inconclusive. Moreover,
it has not been studied whether a low ABI provides informa-
tion on the future cardiovascular risk after stroke or TIA
independently of other risk markers.
In this study, we examined the association between low
ABI and the subsequent long-term risk of stroke, MI, or death
in patients with acute ischemic stroke or TIA. We also
examined whether this association was independent of age,
vascular risk factors, cardiovascular comorbidities, and cer-
vical or intracranial artery stenosis.
Patients and Methods
We recruited an inception cohort of 204 consecutive patients with
acute ischemic stroke or TIA who were admitted to the Neurology
Department of Charité Hospital in Berlin, Germany, between August
2002 and March 2003 (n87) and between October 2003 and June
2004 (n117). Diagnosis of ischemic stroke or TIA was verified by
a stroke neurologist (F.M. or M.A.B.) on the basis of the clinical
syndrome and results of diagnostic tests, including computed tomog-
raphy and magnetic resonance imaging scans and cardiac and
vascular tests. Patients who died or were comatose during the first
week after the index event were excluded. The study was approved
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by the local research ethics committee, and all participants or their
proxies gave written, informed consent.
ABI Measurement
Ankle and brachial systolic blood pressures were measured at
baseline with an aneroid sphygmomanometer and a hand-held
8-MHz Doppler probe (ELCAT handydop, Wolfratshausen, Ger-
many) with the subject in the supine position after a 5-minute rest.
According to American Heart Association recommendations,2 the
ABI was calculated as the ratio of the higher of the systolic pressures
in the posterior tibial or dorsalis pedis artery and the average of the
right and left brachial artery pressures (in the case of a discrepancy
10 mm Hg between the arms, the higher reading was used). This
method has been shown to result in the most accurate estimation of
PAD prevalence in the general population.9 ABI was calculated
separately for each leg, and the lower of the 2 ABI values was used
for analysis. In accordance with the Transatlantic Intersociety Con-
sensus for the management of PAD10 and previous studies in patients
with stroke or TIA,7,8 ABI values 0.9 were defined as low. Patients
were assessed within the first week of admission by 2 trained
examiners (J.-E.R. and K.L.).
Outcome Measures
The main outcome was the composite of stroke, MI, or death during
follow-up. To screen for outcome events, patients and their family
doctors were interviewed by telephone and were additionally asked
to complete a postal questionnaire. Possible outcome events were
investigated from hospital records, hospital discharge letters, and
family doctor information. Only definite, ie, physician-diagnosed,
events were included in the analysis. Recurrent stroke was diagnosed
only if symptoms lasted for 24 hours or new lesions were
demonstrated on computed tomography or magnetic resonance
imaging brain scans. Complete mortality follow-up was achieved by
identifying deaths from death records at the regional civil registration
office. Cause of death was obtained from hospital records and death
certificates and classified as vascular, nonvascular, and unknown.
Last follow-up assessments were made in the summer of 2007.
Covariates
Demographic and clinical data at baseline were obtained from
medical records and electronic hospital information systems with
standardized data collection forms. Data on medical history, previous
medications, and risk factors were confirmed by consultation with
family doctors and patients or relatives.
The index event was classified as a TIA if neurologic symptoms
resolved within 24 hours and as stroke if they persisted for 24
hours. Etiology of stroke or TIA was classified according to the Trial
of ORG 10172 in Acute Stroke Treatment criteria as atherosclerotic
(symptomatic cervical or intracranial artery stenosis 50%, other
causes excluded), cardioembolic (cardiac source of embolism, other
causes excluded), lacunar (clinical lacunar syndrome, brain infarct
1.5 cm, other causes excluded), other determined etiology, multi-
ple possible etiologies (eg, concurrent atherosclerotic stenosis and
cardiac source of embolism), and undetermined.11 Because there
were only a few patients in the last 3 categories and no difference in
the prevalence between ABI groups was noted, these categories were
combined for analysis.
Vascular risk factors assessed at baseline included hypertension
(blood pressure 140/90 mm Hg, current antihypertensive therapy,
or previous physician diagnosis), diabetes mellitus (fasting glucose
126 mg/dL, nonfasting glucose 200 mg/dL, current antidiabetic
therapy, or previous physician diagnosis), hyperlipidemia (fasting
total cholesterol 220 mg/dL, fasting triglycerides 150 mg/dL, or
current therapy with lipid-lowering drugs), and smoking status
(current, past, or never smoking).
Cardiovascular comorbidities included physician-confirmed his-
tory of stroke, MI, coronary heart disease (CHD: stable or unstable
angina, MI, or coronary surgery or angioplasty), or atrial fibrillation
as verified from medical records, discharge letters, or family doctors.
History of PAD was defined as previous physician diagnosis of
PAD, history of intermittent claudication caused by a confirmed
stenosis of a leg artery, or history of peripheral arterial surgery,
angioplasty, or amputation for PAD.
Cervical or intracranial artery stenosis 50% was diagnosed by
routine vascular tests, with 96% of patients being examined by
Doppler and duplex ultrasound and 43% being examined by com-
puted tomography angiography, magnetic resonance angiography, or
intra-arterial angiography. Symptomatic stenosis 50% was defined
as stenosis of a cervical or intracranial artery that was considered
likely to be responsible for the index event.
Statistical Analysis
We analyzed the survival time from the index event to the date of the
first outcome event (stroke, MI, or death). Patients without outcome
events were right-censored at their last follow-up date. We estimated
outcome rates per person-years of follow-up and rate ratios compar-
ing patients with low (0.9) and normal (0.9) ABI for the main
composite outcome and additionally for individual outcome events.
All other analyses were done for the main composite outcome.
Outcome-free survival was examined with Kaplan–Meier curves,
with comparisons between ABI groups made with stratified survival
curves. Cox regression analysis was used to estimate hazard ratios
(HRs) and 95% CIs for the effects of low ABI and other baseline
variables on outcome. Because age is associated with the prevalence
of low ABI3 and cardiovascular risk,12 further analyses were adjusted
for age by using chronological age as the time scale in survival
analysis.13,14
Multivariable Cox regression analysis was used to examine
whether the association between low ABI and outcome was con-
founded by age, sex, stroke etiology, risk factors, or cardiovascular
comorbidities. To avoid overfitting, separate models were fitted that
were adjusted for age and stroke etiology and included low ABI as
the exposure of interest and 1 risk factor or comorbidity variable at
a time. A final model included all variables that were associated with
outcome to the P0.1 significance level or were relevant confound-
ers of the effect of low ABI; ie, their inclusion changed the HR
associated with low ABI by 10%. Effect modification by sex and
index event (stroke or TIA) was assessed in stratified analysis with
Mantel-Cox methods and 2 tests for interaction. All statistical
analyses were performed with STATA 9.2 (Stata Corp, College
Station, Tex).
Results
The mean ABI at baseline among all 204 patients was 0.95
(SD0.23; range, 0.21 to 1.5). An ABI 0.9 was found in 63
patients (31%), of whom 29% had a history of PAD,
compared with 4% of 141 patients with a normal ABI
(P0.001). Baseline characteristics of participants are sum-
marized in Table 1. Patients with a low ABI were, on average,
4.6 years older and more likely to be current smokers, to have
hypertension, and to have any cervical or intracranial artery
stenosis 50%.
Complete follow-up information was available for 197
patients (97%). Of the remaining, 2 could not be traced, 2
declined follow-up, and 3 were alive but no other information
was available. Mean time to first outcome event or last
follow-up was 2.3 years (SD1.0; range, 0.2 to 3.9 years),
with similar follow-up times in patients with low (meanSD,
2.21.1 years) and normal (meanSD, 2.40.9 years) ABI
(Mann–Whitney U test, P0.3).
During a total of 453.0 person-years of follow-up, 37
patients experienced outcome events (28 strokes [4 fatal] in
23 patients, 4 MIs [2 fatal], and 20 deaths), an unadjusted
outcome rate of 8.2% (95% CI, 5.9 to 11.3) per person-year.
Outcome rate was higher among patients with a low ABI
(12.8% per year; 95% CI, 7.9 to 20.5) compared with those
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with a normal ABI (6.3% per year; 95% CI, 4.0 to 9.7), a rate
ratio of 2.0 (95% CI, 1.1 to 3.9; P0.03). With regard to
individual outcome events, there was some evidence for an
increased mortality in the low-ABI group (Table 2), whereas
rates for stroke and MI were nonsignificantly higher. Among
20 deceased patients, the cause of death was vascular in 9
(45%), nonvascular in 9 (45%), and unknown in 2 (10%),
with no difference between ABI groups (Fisher’s exact test,
P0.5).
Kaplan–Meier curves (the Figure) show a lower probabil-
ity of outcome-free survival among patients with a low ABI
compared with those with a normal ABI (log-rank test,
P0.02). In univariate Cox regression analysis, patients with
a low ABI had a 2 times higher risk of stroke, MI, or death
(HR2.0; 95% CI, 1.1 to 3.9; Table 3). Other factors
associated with the composite outcome in univariate analysis
were age, stroke etiology, and atrial fibrillation. After adjust-
ment for age, the effect of low ABI on outcome was slightly
increased (HR2.2; 95% CI, 1.1 to 4.3). There was still some
weak evidence for an association between stroke etiology and
outcome, mainly owing to a better survival among patients
with lacunar stroke (HR0.2; 95% CI, 0.1 to 0.9), but no
other baseline variable predicted outcome in age-adjusted
analysis.
From the multivariable models adjusted for age, stroke
etiology, and 1 risk factor or comorbidity variable at a time,
there was no evidence that the effect of low ABI on outcome
was confounded by any other baseline variable; ie, the HR
associated with low ABI remained materially unchanged,
ranging between 2.1 and 2.3 in all models. Also, none of the
other baseline variables, including PAD, was associated with
outcome in these multivariable models. In the final model
adjusting for age and stroke etiology, the HR associated with
low ABI was 2.2 (95% CI, 1.1 to 4.5). There was no evidence
that the association between low ABI and outcome was modified
by sex or index event (stroke or TIA) in stratified analyses (2
tests for interaction, P0.9 and P0.6, respectively).
Discussion
In this inception cohort study of hospital-admitted patients
with acute ischemic stroke or TIA, a low ABI was found in
nearly a third of patients and independently predicted an
increased long-term risk of subsequent cardiovascular events
or death. These results suggest that measurement of the ABI
may help to identify patients with stroke or TIA who are at
increased cardiovascular risk beyond established risk markers
and who could potentially benefit from a targeted, intensified,
secondary prevention treatment.







P *n (%) n (%) n (%)
Female sex 91 (45) 32 (51) 59 (42) 0.2
Mean age (SD), y 63.9 (13.2) 67.1 (11.8) 62.5 (13.6) 0.02
Index event
Stroke 154 (75) 52 (83) 102 (72) 0.1
TIA 50 (25) 11 (17) 39 (28)
Etiologic subtype†
Atherosclerotic 46 (23) 18 (29) 28 (20) 0.4
Cardioembolic 61 (30) 19 (30) 42 (30)
Lacunar 57 (28) 15 (24) 42 (30)
Other or
undetermined
40 (19) 11 (17) 29 (20)
Risk factors
Hypertension 142 (70) 51 (81) 91 (65) 0.02
Diabetes 66 (32) 25 (40) 41 (29) 0.1
Hyperlipidemia 85 (42) 32 (51) 53 (38) 0.08
Current smoking 60 (29) 26 (41) 34 (24) 0.01
Cardiovascular
comorbidities
Previous stroke 45 (22) 19 (30) 26 (18) 0.06
Previous MI 25 (12) 9 (14) 16 (11) 0.6
Atrial fibrillation 36 (18) 14 (22) 22 (17) 0.3
History of CHD 37 (18) 14 (22) 23 (16) 0.3





85 (42) 34 (54) 51 (36) 0.02
Symptomatic
stenosis
67 (33) 24 (38) 43 (31) 0.3
*P values for comparison of ABI groups were obtained from the Mann–Whitney
U test for age and from the 2 test or Fisher exact test for other variables.
†Subtype according to TOAST classification (see text for details).
Table 2. Outcome Rates per Person-Year According to ABI Category
ABI 0.9 (n61) ABI 0.9 (n136)
n* Person-Years† Rate n* Person-Years† Rate Rate Ratio (95% CI) P
Composite outcome
Stroke, MI, or death 17 133 12.8% 20 320 6.3% 2.0 (1.1–3.9) 0.03
Individual outcomes
Stroke 9 133 6.8% 14 320 4.4% 1.5 (0.7–3.6) 0.3
MI 2 143 1.4% 2 333 0.6% 2.3 (0.3–16.0) 0.4
Death 10 143 7.0% 10 334 3.0% 2.3 (1.0–5.6) 0.05
*No. of patients with at least 1 outcome event. Note: n for composite outcome is smaller than the sum of individual outcomes owing
to multiple outcome events in some patients.
†Person-years of follow-up until first outcome event or last follow-up.
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The high prevalence of a low ABI of 31% in this study
indicates that nearly a third of patients with stroke or TIA had
coexisting PAD. Although patients with a history of PAD
were more likely to have low ABI values than those without,
the vast majority of low ABI values (71%) were found in
previously undiagnosed and asymptomatic patients.
These results are comparable to the findings of 3 recent
studies that reported ABI prevalence in patients with cere-
brovascular disease.7,15–17 In the German Epidemiological
Trial on Ankle Brachial Index (getABI),15,16 the prevalence of
ABI 0.9 was 18.0% in the total sample of 6880 unselected
primary care patients and 30.3% in 607 patients with a history
of cerebrovascular disease. The Italian PATHOS study7
examined 1758 patients admitted to 1 of 49 hospital depart-
ments for acute coronary syndromes (57%), acute ischemic
stroke (29%), or TIA (14%); the prevalence of ABI 0.9 was
34% among 755 patients with stroke or TIA. In the SCALA
study,17 the prevalence of ABI 0.9 was higher, at 51%
among 852 patients with stroke or TIA admitted to 85 stroke
units across Germany. This higher prevalence may partly be
explained by a higher mean age and a higher proportion of
patients with atherosclerotic stroke in SCALA. As in our
study, only a small minority of patients with a low ABI in
these 3 studies had a history of PAD, ranging from 7% in
PATHOS7 to 20% in SCALA.17
There was a lower prevalence of low ABI (9%) among
participants of the ARIC study with a history of stroke or
TIA,18 but the prevalence of PAD might have been underes-
timated because the ABI was measured in 1 leg only.19 A
Japanese study, which reported a prevalence of low ABI of
17%, had analyzed 58 retrospectively selected patients with
ischemic stroke.20
Although low ABI has been consistently associated with
the incidence of cardiovascular disease and mortality in the
general population,1,3 evidence on the role of the ABI as a
predictor of recurrent cardiovascular events or death in
individuals with prevalent cardiovascular disease is limited
and less consistent. In the large population-based ARIC
study, the association between low ABI and recurrence of
CHD events or stroke in 766 individuals with prevalent CHD
was weak and no longer significant after adjustment for
Figure. Kaplan–Meier estimates of the
probability of survival free of stroke or
MI, stratified by ABI category.
Table 3. Associations Between Baseline Variables and Risk of
Stroke, MI, or Death During Follow-Up (n197)
Univariate Analysis Age-Adjusted Analysis
HR 95% CI P HR 95% CI P
Low ABI 2.0 1.1–3.9 0.03 2.2 1.1–4.3 0.02
Age 65 y 2.5 1.2–5.1 0.007
Female sex 1.3 0.7–2.4 0.5 1.3 0.7–2.7 0.4
Etiologic subtype
Atherosclerotic 1.0 0.008 1.0 0.06
Cardioembolic 1.5 0.7–3.2 0.9 0.4–2.3
Lacunar 0.2 0.1–0.9 0.2 0.1–0.9
Other or undetermined 0.9 0.4–2.4 0.8 0.3–2.0
Risk factors
Hypertension 1.9 0.8–4.4 0.1 1.6 0.6–3.9 0.3
Diabetes 1.8 0.9–3.4 0.1 1.5 0.8–3.1 0.2
Hyperlipidemia 0.6 0.3–1.3 0.2 0.7 0.3–1.4 0.3
Current smoking 0.6 0.3–1.4 0.3 1.0 0.4–2.3 0.9
Cardiovascular
comorbidities
Previous stroke 1.7 0.8–3.4 0.2 1.7 0.8–3.6 0.2
Previous MI 1.5 0.6–3.5 0.4 1.5 0.6–3.9 0.4
Atrial fibrillation 2.7 1.4–5.4 0.006 1.5 0.6–3.5 0.4
History of CHD 1.8 0.9–3.8 0.1 1.8 0.8–3.9 0.2
History of PAD 2.1 0.9–4.7 0.08 2.0 0.8–4.8 0.1
Cervical or
intracranial stenosis
Any stenosis 50% 1.4 0.7–2.6 0.3 1.7 0.8–3.3 0.2
Symptomatic stenosis 1.1 0.6–2.2 0.8 1.6 0.8–3.3 0.2
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cardiovascular risk factors.19 In a study of 165 patients with
CHD referred for elective coronary angiography, low ABI
predicted the risk of subsequent acute cardiovascular events
after adjustment for age, cholesterol, and carotid atheroscle-
rosis.21 In a study of 1101 patients with acute coronary
syndromes, low ABI was associated with higher in-hospital
mortality and short-term recurrence of angina.22 Among
participants of the Italian PATHOS study with acute coronary
syndromes, patients with a low ABI had a higher 1-year risk
of MI, stroke, or death (odds ratio2.35; 95% CI, 1.47 to
3.76), and this association remained significant after adjust-
ment for risk factors and prognostic markers.7
The association between ABI and subsequent cardiovascu-
lar risk and mortality in patients with acute ischemic stroke or
TIA has been explored in only 2 previous studies. The
PATHOS study found an increased 1-year risk of stroke, MI,
or death in patients with TIA but not in those with stroke and
not when both groups were analyzed together.7 The authors
noted that these inconclusive results may partly be explained
by the relatively short follow-up of 1 year, the exclusion of
patients with cardioembolic stroke or TIA, and potentially by
differences in treatment intensity. Also, the analysis of
patients with stroke or TIA was not adjusted for age and risk
factors. In the SCALA study, an increased risk of recurrent
stroke or cardiovascular death during a mean follow-up of
17.5 months was found in patients with low ABI.8 However,
the analysis was not adjusted for potential confounders such
as age, risk factors, or cardiovascular comorbidities, and it
was not reported whether patients with low and normal ABI
values differed in these important prognostic factors. More-
over, MI was not assessed as an outcome.
The main advantages of our study are the adjustment for
relevant confounders in multivariable survival analysis and
the longer follow-up times compared with those in previous
studies. There are, however, several limitations to our study
that merit discussion. Owing to the low number of outcome
events, the analysis was not powered to identify significant
associations between low ABI and individual outcomes,
although rates for individual outcomes were higher in patients
with ABI 0.9. For the same reason, we could not control for
all covariates at the same time in the multivariable model, and
a small effect of individual covariates on outcome may have
been missed. We could not examine the influence of second-
ary prevention treatment, as data on medication adherence
during follow-up was missing for 12% of patients. However,
there was no evidence that adherence to antithrombotic
medication influenced the outcome of patients with available
information. The study was suspended from April to Septem-
ber 2003 because restructuring of local stroke services in
combination with a shortage of study personnel meant that we
could not guarantee complete ascertainment and assessment
of all admitted patients with stroke or TIA during that time.
However, there was no evidence for an effect of study period
on baseline characteristics or study outcomes in univariate
and multivariate analyses. Finally, our findings apply only to
hospital-admitted patients with acute TIA or stroke. Larger
population-based studies are needed to confirm the results,
particularly with regard to individual outcomes such as stroke
recurrence.
Conclusions
The results suggest that a low ABI independently predicts
long-term cardiovascular risk and mortality in patients with
acute stroke or TIA. Measurement of the ABI may help to
identify high-risk patients for intensified secondary stroke
prevention, including more aggressive treatment of hyperten-
sion, dyslipidemia, and diabetes. Moreover, ABI measure-
ment may be used to facilitate risk education and increase risk
awareness, thus potentially improving medication adherence
and participation in smoking cessation and exercise pro-
grams. Before the value of a targeted approach to stroke
prevention can be tested in intervention trials, further evalu-
ation is required of the potential of incorporating ABI
measurement in risk scores and risk stratification systems on
which secondary prevention strategies are based.
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